265.86
price down icon2.28%   -6.19
 
loading
Amgen Inc stock is traded at $265.86, with a volume of 3.33M. It is down -2.28% in the last 24 hours and down -8.67% over the past month. Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
See More
Previous Close:
$272.05
Open:
$270.66
24h Volume:
3.33M
Relative Volume:
1.10
Market Cap:
$151.21B
Revenue:
$34.13B
Net Income/Loss:
$5.93B
P/E Ratio:
24.26
EPS:
10.96
Net Cash Flow:
$10.92B
1W Performance:
-5.46%
1M Performance:
-8.67%
6M Performance:
-18.27%
1Y Performance:
-15.02%
1-Day Range:
Value
$265.66
$273.48
1-Week Range:
Value
$265.66
$281.97
52-Week Range:
Value
$253.30
$346.85

Amgen Inc Stock (AMGN) Company Profile

Name
Name
Amgen Inc
Name
Phone
(805)447-1000
Name
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Name
Employee
28,000
Name
Twitter
@amgen
Name
Next Earnings Date
2025-02-04
Name
Latest SEC Filings
Name
AMGN's Discussions on Twitter

Compare AMGN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - General icon
AMGN
Amgen Inc
265.86 151.21B 34.13B 5.93B 10.92B 10.96
Drug Manufacturers - General icon
LLY
Lilly Eli Co
734.57 739.39B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
154.22 375.64B 89.33B 21.81B 18.57B 8.99
Drug Manufacturers - General icon
ABBV
Abbvie Inc
184.60 351.09B 57.37B 4.20B 17.83B 2.35
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
65.77 307.32B 43.59B 15.04B 10.74B 3.3766
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
108.70 225.73B 53.22B 12.86B 14.85B 6.39

Amgen Inc Stock (AMGN) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-22-25 Resumed Cantor Fitzgerald Neutral
Dec-10-24 Resumed BofA Securities Underperform
Nov-15-24 Initiated Wolfe Research Peer Perform
Nov-14-24 Initiated Citigroup Neutral
Oct-17-24 Initiated Bernstein Outperform
Oct-14-24 Downgrade Truist Buy → Hold
Sep-27-24 Initiated Cantor Fitzgerald Overweight
Aug-07-24 Downgrade Wells Fargo Overweight → Equal Weight
May-03-24 Upgrade Barclays Underweight → Equal Weight
May-03-24 Upgrade William Blair Mkt Perform → Outperform
Mar-28-24 Resumed Raymond James Mkt Perform
Feb-07-24 Downgrade Leerink Partners Outperform → Market Perform
Dec-21-23 Upgrade Daiwa Securities Neutral → Buy
Dec-19-23 Upgrade BMO Capital Markets Market Perform → Outperform
Dec-12-23 Upgrade RBC Capital Mkts Sector Perform → Outperform
Nov-09-23 Initiated Deutsche Bank Hold
Nov-02-23 Upgrade Truist Hold → Buy
Oct-20-23 Resumed JP Morgan Neutral
Oct-17-23 Resumed Morgan Stanley Equal-Weight
Oct-11-23 Resumed BofA Securities Neutral
Sep-06-23 Initiated HSBC Securities Buy
Apr-24-23 Reiterated Oppenheimer Outperform
Mar-13-23 Upgrade Wells Fargo Equal Weight → Overweight
Feb-13-23 Reiterated Truist Buy
Nov-18-22 Initiated Credit Suisse Underperform
Oct-31-22 Downgrade Barclays Equal Weight → Underweight
Oct-11-22 Upgrade Morgan Stanley Equal-Weight → Overweight
May-23-22 Initiated SVB Leerink Mkt Perform
Feb-09-22 Reiterated Barclays Equal Weight
Feb-09-22 Reiterated Jefferies Buy
Feb-09-22 Reiterated Morgan Stanley Equal-Weight
Feb-09-22 Reiterated Oppenheimer Outperform
Feb-09-22 Reiterated Wells Fargo Equal Weight
Jan-05-22 Downgrade BofA Securities Buy → Neutral
Dec-09-21 Resumed Wells Fargo Equal Weight
Dec-06-21 Initiated Goldman Buy
Nov-19-21 Initiated BMO Capital Markets Market Perform
Sep-23-21 Downgrade Daiwa Securities Outperform → Neutral
Sep-07-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-29-20 Initiated Daiwa Securities Buy
Oct-28-20 Initiated UBS Neutral
Oct-26-20 Upgrade Raymond James Mkt Perform → Outperform
Oct-12-20 Upgrade Truist Hold → Buy
Oct-09-20 Downgrade Bernstein Outperform → Mkt Perform
Oct-09-20 Downgrade Truist Buy → Hold
Oct-08-20 Downgrade Raymond James Outperform → Mkt Perform
Apr-15-20 Resumed Guggenheim Neutral
Mar-31-20 Initiated Wolfe Research Peer Perform
Mar-30-20 Upgrade Raymond James Mkt Perform → Outperform
Mar-05-20 Upgrade BofA/Merrill Neutral → Buy
Feb-27-20 Initiated Barclays Equal Weight
Jan-31-20 Downgrade Robert W. Baird Neutral → Underperform
Jan-21-20 Upgrade Evercore ISI In-line → Outperform
Dec-24-19 Initiated Raymond James Mkt Perform
Dec-17-19 Resumed Morgan Stanley Overweight
Nov-12-19 Initiated SunTrust Buy
Nov-05-19 Upgrade Cantor Fitzgerald Neutral → Overweight
Oct-17-19 Resumed BofA/Merrill Neutral
Aug-19-19 Downgrade Mizuho Buy → Neutral
May-23-19 Upgrade Citigroup Neutral → Buy
View All

Amgen Inc Stock (AMGN) Latest News

pulisher
04:37 AM

Bridgefront Capital LLC Grows Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

04:37 AM
pulisher
02:10 AM

Rep. Marjorie Taylor Greene Purchases Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

02:10 AM
pulisher
01:49 AM

BLI Banque de Luxembourg Investments Purchases Shares of 8,483 Amgen Inc. (NASDAQ:AMGN) - MarketBeat

01:49 AM
pulisher
01:29 AM

Alethea Capital Management LLC Takes $347,000 Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

01:29 AM
pulisher
01:20 AM

Bellevue Group AG Has $23.26 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

01:20 AM
pulisher
May 09, 2025

BNP Paribas Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

May 09, 2025
pulisher
May 09, 2025

Bayesian Capital Management LP Purchases Shares of 43,000 Amgen Inc. (NASDAQ:AMGN) - MarketBeat

May 09, 2025
pulisher
May 09, 2025

Banque Transatlantique SA Acquires Shares of 1,712 Amgen Inc. (NASDAQ:AMGN) - MarketBeat

May 09, 2025
pulisher
May 09, 2025

AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE | AMGN Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Amgen outlook revised to stable at S&P, debt reduction continues - Investing.com

May 09, 2025
pulisher
May 09, 2025

Moms (and Kids) Thrive at Amgen - Amgen

May 09, 2025
pulisher
May 09, 2025

Navigating the Trump tariffs, part two: Amgen, Biogen, others - BioWorld MedTech

May 09, 2025
pulisher
May 09, 2025

Diligent Investors LLC Sells 2,643 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

May 09, 2025
pulisher
May 09, 2025

Amgen (NASDAQ:AMGN) Price Target Raised to $280.00 - MarketBeat

May 09, 2025
pulisher
May 09, 2025

Cornerstone Select Advisors LLC Takes $820,000 Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

May 09, 2025
pulisher
May 09, 2025

Cresset Asset Management LLC Has $13.53 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

May 09, 2025
pulisher
May 09, 2025

Cary Street Partners Financial LLC Takes $3.04 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

May 09, 2025
pulisher
May 09, 2025

Where are the Opportunities in (AMGN) - news.stocktradersdaily.com

May 09, 2025
pulisher
May 09, 2025

Amgen Inc. (NASDAQ:AMGN) Holdings Decreased by Caisse DE Depot ET Placement DU Quebec - MarketBeat

May 09, 2025
pulisher
May 08, 2025

Aristotle Capital Management LLC Sells 16,789 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

May 08, 2025
pulisher
May 08, 2025

Accredited Wealth Management LLC Takes $847,000 Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

May 08, 2025
pulisher
May 08, 2025

Amgen CEO Robert A. Bradway to Receive Honorary Degree from KGI - Eagle-Tribune

May 08, 2025
pulisher
May 08, 2025

Amgen CEO Robert A. Bradway to Receive Honorary Degree from KGI - GlobeNewswire Inc.

May 08, 2025
pulisher
May 08, 2025

38,090 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by Cutter Capital Management LP - MarketBeat

May 08, 2025
pulisher
May 08, 2025

Capital Advantage Inc. Purchases New Shares in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

May 08, 2025
pulisher
May 08, 2025

Erste Group cuts Amgen stock rating to Hold from Buy - Investing.com

May 08, 2025
pulisher
May 08, 2025

MHRA approves Amgen’s Tepezza for TED - The Pharma Letter

May 08, 2025
pulisher
May 08, 2025

Amgen (AMGN) Downgraded by Analyst Due to Future Growth Concerns | AMGN Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

MHRA approves Amgen’s Tepezza for NED - The Pharma Letter

May 08, 2025
pulisher
May 08, 2025

Amgen Inc. (NASDAQ:AMGN) Stock Holdings Lessened by AQR Capital Management LLC - MarketBeat

May 08, 2025
pulisher
May 08, 2025

Baird Financial Group Inc. Sells 10,812 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

May 08, 2025
pulisher
May 08, 2025

Alteri Wealth LLC Purchases Shares of 11,903 Amgen Inc. (NASDAQ:AMGN) - MarketBeat

May 08, 2025
pulisher
May 07, 2025

UK's MHRA Approves Amgen's Thyroid Eye Disease Treatment - marketscreener.com

May 07, 2025
pulisher
May 07, 2025

Amgen Inc. (NASDAQ:AMGN) Shares Bought by Ameriprise Financial Inc. - MarketBeat

May 07, 2025
pulisher
May 07, 2025

Mercer Global Advisors Inc. ADV Acquires New Shares in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

May 07, 2025
pulisher
May 07, 2025

Amgen's (AMGN) Tepezza Gains U.K. Approval for Thyroid Eye Disease - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Amgen Inc. (AMGN): A Bull Case Theory - Insider Monkey

May 07, 2025
pulisher
May 07, 2025

Is Amgen Inc. (AMGN) the Best Dow Stock? - MSN

May 07, 2025
pulisher
May 07, 2025

Amgen wins U.K. nod for Tepezza in TED (AMGN:NASDAQ) - Seeking Alpha

May 07, 2025
pulisher
May 07, 2025

What the Options Market Tells Us About Amgen - Nasdaq

May 07, 2025
pulisher
May 07, 2025

Amgen (AMGN) Gains UK Approval for Tepezza in Thyroid Eye Disease Treatment | AMGN Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Amgen says MHRA granted marketing authorization to Tepezza for TED - TipRanks

May 07, 2025
pulisher
May 07, 2025

Amgen’s TEPEZZA®▼ (teprotumumab) Granted Marketing Authorisation as the First Targeted Treatment Specifically for Adults With Moderate-to-severe Thyroid Eye Disease (TED) in the United Kingdom - Business Wire

May 07, 2025
pulisher
May 07, 2025

The Best and Worst Dow Stocks - Insider Monkey

May 07, 2025
pulisher
May 07, 2025

Forecasting The Future: 7 Analyst Projections For Amgen - Benzinga

May 07, 2025
pulisher
May 07, 2025

Here's Why Amgen (AMGN) is a Strong Growth Stock - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Analyst Update: Amgen (AMGN) Price Target Raised to $280 by Mizuho | AMGN Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Amgen (AMGN) Price Target Increased by Mizuho Following Q1 Updat - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Captrust Financial Advisors Buys 10,753 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

May 07, 2025
pulisher
May 07, 2025

Brown Advisory Inc. Purchases 49,109 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

May 07, 2025
pulisher
May 07, 2025

Benjamin Edwards Inc. Raises Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

May 07, 2025

Amgen Inc Stock (AMGN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
drug_manufacturers_general PFE
$22.28
price down icon 3.00%
drug_manufacturers_general SNY
$49.90
price down icon 4.28%
$96.91
price down icon 1.27%
drug_manufacturers_general MRK
$75.97
price down icon 2.16%
drug_manufacturers_general NVS
$108.70
price down icon 1.30%
Cap:     |  Volume (24h):